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The transmission of the prion disease bovine spongi-
form encephalopathy (BSE) to humans raises concern
about chronic wasting disease (CWD), a prion disease of
deer and elk. In 7 Colorado counties with high CWD preva-
lence, 75% of state hunting licenses are issued locally,
which suggests that residents consume most regionally
harvested game. We used Colorado death certificate data
from 1979 through 2001 to evaluate rates of death from the
human prion disease Creutzfeldt-Jakob disease (CJD). The
relative risk (RR) of CJD for CWD-endemic county resi-
dents was not significantly increased (RR 0.81, 95% confi-
dence interval [CI] 0.40–1.63), and the rate of CJD did not
increase over time (5-year RR 0.92, 95% CI 0.73–1.16). In
Colorado, human prion disease resulting from CWD expo-
sure is rare or nonexistent. However, given uncertainties
about the incubation period, exposure, and clinical presen-
tation, the possibility that the CWD agent might cause
human disease cannot be eliminated.
A
n emerging wildlife epizootic of chronic wasting dis-
ease (CWD) (1), a contagious prion disease among
mule deer, white-tailed deer, and Rocky Mountain elk, has
potential public health implications (2–5). CWD is related
to other mammalian transmissible spongiform encephalo-
pathies (TSEs), such as Creutzfeldt-Jakob disease (CJD) in
humans, bovine spongiform encephalopathy (BSE) in cat-
tle, and scrapie in sheep. In prion diseases, a normally pro-
duced cellular protein accumulates in an abnormal,
misfolded, and aggregated form (6), which results in neu-
ron destruction and a universally fatal outcome after a pro-
longed incubation period.
CWD infects wild and captive deer and elk in several
US states and Canadian provinces. The highest reported
disease prevalence is in a contiguous region, spanning
parts of Colorado, Wyoming, and Nebraska (Figure 1),
where the estimated disease prevalence is 5% in mule deer,
2% in white-tailed deer, and 0.5% in elk (7). CWD was
first noted in captive deer at a research station in north-
central Colorado near Fort Collins in the 1960s (1) and
later in a wild elk near Estes Park in 1981 (8). No clear epi-
demiologic connections have been found between original
cases and more recent cases, which suggests that unidenti-
fied risk factors may be contributing to the relatively wide
and unpredictable geographic distribution of CWD (2−4).
Humans and animals can acquire TSEs by consuming
prion-contaminated food. Outbreaks of prion disease
include an epidemic of kuru among the cannibalistic Fore
tribe of the New Guinea highlands (9) and an epizootic of
BSE in the United Kingdom, caused by feeding to cattle
protein supplements derived from prion-infected cattle
offal (10). Food-based prion transmission between species
also occurs, although a phenomenon known as the “species
barrier” decreases transmission efficiency. In vitro studies
(11,12) indicate that this natural barrier reduces human
susceptibility to animal prion diseases, including CWD. As
yet, no cases of human prion disease have been linked with
CWD (5,13–15), and natural transmission of CWD to
humans or traditional domestic livestock seems unlikely
(2,3,5,12,14,16,17).
The otherwise reassuring molecular evidence of species
barriers is clouded by the disparate experiences with
scrapie and BSE as foodborne human pathogens. Scrapie
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despite extensive human exposure (18). Conversely, in
Britain the consumption of BSE-infected cattle led to an
epidemic of variant CJD (vCJD), beginning in the mid-
1990s (19–23). As of June 2006, however, only 161 cases
of vCJD have been identified in the United Kingdom (24),
despite the dietary exposure of millions of Britons to the
BSE agent. In addition, recent studies indicate that large
numbers of cases of vCJD are unlikely to occur in Britain
in the future (25). Because the CWD agent is distinct from
the BSE agent (12,26–29) and the type and degree of
human exposure to these 2 agents differ, the risk for CWD
transmission to humans cannot be directly extrapolated
from the BSE and vCJD epidemics (30).
Because no completely reliable experimental animal
model exists for testing the potential for CWD to cause
CJD (30), human case investigations and epidemiologic
studies remain valuable tools for assessing the potential
risk associated with CWD exposure (5). Data that define
human CWD exposure from consumption of infected deer
or elk do not exist. However, in 7 northeastern Colorado
counties (Boulder, Larimer, Logan, Morgan, Phillips,
Sedgwick, and Weld) that are considered CWD-endemic
areas (7) (Figure 1), the Colorado Division of Wildlife
(CDOW) hunter license records indicate ≈75% (38,458 of
51,048) of deer and elk hunting licenses purchased from
1995 through 2001 were issued locally (CDOW, unpub.
data), which suggests that county residents consume most
regionally harvested game. Using Colorado death certifi-
cate data from 1979 through 2001, we modeled whether
residence in a CWD-endemic county affected the risk-
adjusted probability that a death is from CJD. We also
examined whether the probability that a death is from CJD
increased over time. To account for the possibility that
CJD may have been misclassified, we also conducted sen-
sitivity analyses using an expanded definition of event,
similar to criteria used by Majeed et al. (31).
Materials and Methods
Study Population
Colorado death certificate data from 1979 through 2001
were used. Deaths during 1979−1998 and 1999−2001 were
classified by the ICD-9 and ICD-10 codes, respectively.
Sporadic CJD is extremely rare in persons <30 years of age
(32), and vCJD cases have not been reported in patients
<12 years (33). Therefore, we restricted all analyses to
deaths occurring at >12 years, which provided 506,335 eli-
gible deaths. We classified deaths as due to CJD if the
codes 046.1 (ICD-9) or A81.0 (ICD-10) were listed as
either the direct or contributory cause (events = 65).
Additional Colorado death certificate data used includ-
ed age at death, sex, and marital status. We considered
marital status as a predictor, because it may influence
whether symptoms are recognized, which subsequently
increases the likelihood of diagnosing CJD. Years of edu-
cation data were not collected before 1989; therefore, this
variable was not considered as a predictor. Figure 2 con-
tains individual characteristics for persons who died in
Colorado with CJD listed on the death certificate and
smoothed population CJD rates (34).
In 1998, the Colorado Department of Public Health and
Environment (CDPHE) initiated human prion disease sur-
veillance. From 1998 through 2001, CDPHE identified 20
Colorado resident deaths consistent with prion disease
(Table 1). For 10 of these 20 deaths, CJD was confirmed
by examination of brain tissue from biopsy or autopsy
specimens. Three deaths were classified as probable CJD;
rapidly progressive dementia clinically consistent with
prion disease was supported by nonspecific tests. Seven of
the 20 CJD deaths were classified as suspected CJD
because the diagnosis was made without autopsy, biopsy,
or supportive testing. In 14 of these 20 deaths, the ICD
code indicated CJD. Inexplicably, the remaining 6 patients
who died (4 with confirmed CJD, 0 with probable CJD,
and 2 with suspected CJD) had a medical record consistent
with CJD, but the deaths were not coded as such. Three of
these deaths (2 with confirmed CJD, 0 with probable CJD,
and 1 with suspected CJD) were identified under our
expanded definition. CDPHE review of the death certifi-
cates for the 6 misclassified deaths found that CJD was not
reported as a cause of death and that the ICD-10 codes
were consistent with the stated cause of death.
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Figure 1. Location of chronic wasting disease (CWD)–endemic
area in northeastern Colorado, USA (7) (gray shading) in relation-
ship to Colorado counties regarded as CWD counties (bold out-
line) for purposes of comparing Creutzfeldt-Jakob disease rates
and relative risk among resident human populations. Statistical Considerations
A review of Colorado death certificates identified 65
deaths with CJD listed on the death certificate from 1979
through 2001; from all causes, 81,916 and 424,419 persons
>12 years died in the CWD-endemic and non–CWD-
endemic counties, respectively. We were interested in test-
ing whether the relative risk (RR) was greater than 1.0,
where RR is the probability of a CJD death, given resi-
dence in a CWD-endemic county, divided by the corre-
sponding probability in a non–CWD-endemic county. The
RR is approximated by the odds ratio for a rare event such
as death from CJD. Assuming a 2-sided χ2 test with a sig-
nificance level of 0.05, we had >85% power to detect an
unadjusted RR of 2.47. Assuming 65 CJD deaths, this cor-
responds to 21 (2.56 cases/10,000 deaths) and 44 (1.04
cases/10,000 deaths) deaths in the CWD-endemic and
non–CWD-endemic counties, respectively.
We conducted separate analyses for the primary predic-
tors of interest: residence in a CWD-endemic county and
death year. The RRs and 95% confidence intervals (CIs)
were estimated by using logistic regression in SAS (SAS
Institute, Cary, NC, USA). Covariates in the multivariable
analysis were death age, sex, ICD classification, and mar-
ital status. The CWD county analysis also was adjusted for
death year. For death year, ICD classification was consid-
ered as an effect modifier.
Results
Characteristics of Persons Who Died
Descriptive characteristics by CWD endemicity of
county are presented in Table 2. Due to the large sample
size, statistical significance was observed for all covari-
ates, although most differences were relatively small.
Those who died in CWD-endemic counties were more
likely to be white, >70 years of age, and married or wid-
owed rather than divorced.
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Figure 2. Colorado deaths 1979–2001 (left axis) with Creutzfeldt-
Jakob disease (CJD) listed as the direct or contributory cause on
the death certificate with age category at death identified by the
plotting symbols 12-30 years (U), 31-55 years (V), 56-70 years
({) and >70 years (). Indicators of CWD-endemic county resi-
dent (§), female (–), and black (X) or other (I) race are also iden-
tified. On the basis of these death certificate data and Colorado
demographic data (34), we also display a smoothed CJD death
rate per million population over time (right axis) (·–·). Univariate Analyses
Univariate analyses allowed us to describe event char-
acteristics. Table 3 contains the univariate RRs and corre-
sponding 95% CIs for available predictors. CWD-endemic
counties contributed 16.18% of total deaths but only
13.85% of deaths with CJD listed on the death certificate
(p = 0.61) (Figure 2). This finding corresponds to an unad-
justed CJD rate in CWD-endemic counties of 1.10/10,000
deaths; in non–CWD-endemic counties, this rate was
1.32/10,000 deaths. We saw a slight decrease in CJD risk
over time (p = 0.54); 43.08% of CJD deaths occurred
before 1989. CJD risk decreased with age of death;
46.15% of CJD deaths occurred in persons 56–70 years of
age and 40.00% in those >70 years. Given this younger
population, predictable changes occurred in the distribu-
tion of marital status.
Multivariable Models
Table 4 contains the adjusted RRs for CWD endemici-
ty of county and year of death. An RR >1.0 is consistent
with the hypothesis of an increased risk for death from
CJD, given residence in a CWD-endemic county. In the
multivariable model, residing in a CWD-endemic county
did not achieve statistical significance (RR 0.80, 95% CI
0.40–1.62). Death year remained not significant after
adjusting for the additional covariates (for every 5-year
increase, RR 0.92, 95% CI 0.73–1.16).
Death Rates 
In addition to analyzing death certificate data, we com-
puted annual age-standardized CJD death rates per million
population (Figure 3) for the CWD-endemic and
non–CWD-endemic counties (34). These population rates
were age-standardized by using the 2001 age distribution
for Colorado. Smoothed age–standardized rates were simi-
lar to the crude population rates for Colorado shown in
Figure 2 (smoothed median 0.88, range 0.65–0.94). As
expected, given the smaller population size, more variabil-
ity was observed for these rates in the CWD-endemic coun-
ties (smoothed median 0.67 per million, range 0.11–1.37),
than the non–CWD-endemic counties (smoothed median
0.96 per million, range 0.73–1.01). Overall, annual crude
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rates in both the disease-endemic counties (smoothed medi-
an 0.52 per million, range 0.09–1.29) and non–disease-
endemic counties (smoothed median 0.85 per million,
range 0.76–1.01) (data not shown).
Expanded Definition Analyses
We considered that if CWD were transmissible to
humans, then it might be manifested with different signs
and symptoms than typical sporadic CJD, resulting in mis-
diagnosis or classification under a different ICD code.
Therefore, in addition to assessing data for CJD, we con-
ducted sensitivity analyses using an expanded definition
(Appendix). This definition increased the number of event
codes to 29 ICD-9 and 30 ICD-10 (events 1,911). These
codes corresponded to neurodegenerative syndromes in
which signs are exhibited that are prominent in some forms
of prion disease. To minimize false-positive results, we did
not consider death from Alzheimer disease after 55 years
of age as an event. In the United Kingdom, most vCJD
cases have occurred in persons <55 years, with a median
age at death of 28 years (range 14–74 years) (35). In addi-
tion, among patients >55 years, the incidence of age-relat-
ed neurodegenerative diseases tends to obscure all but
dramatic increases in conditions that may be attributable to
CWD exposure. Therefore, to increase specificity, we also
considered the expanded definition restricted to deaths in
persons 12–55 years, which provided 89,033 eligible
deaths (events 339). The adjusted expanded definition RRs
for CWD endemicity of county and year of death are con-
tained in Table 4. Under the expanded definition, we see a
decrease in risk over time (p<0.0001), although signifi-
cance is lost when the analysis is restricted to deaths of
those who died before the age of 55 years.
Discussion
CWD has occurred in free-ranging deer and elk in
northeastern Colorado for >25 years (7,8), so some per-
sons likely have been exposed to the CWD agent. The
human risk from exposure to CWD cannot be quantified
because identifying exposed persons is not possible. The
CDOW records indicate that ≈75% of deer and elk hunting
licenses in 7 northeastern Colorado counties with high
CWD prevalence are issued locally, which indicates that
residents consume most game harvested in this region.
Using Colorado death certification data from 1979 through
2001, we modeled the risk for a CJD death with CWD-
endemic county residence as the exposure of interest.
Similarly, we examined whether CJD deaths have
increased overall. Given the possibility of misclassifica-
tion of CJD and human TSEs, sensitivity analyses were
conducted for expanded event definitions.
Human prion disease is rare, and increased risk due to
CWD exposure appears to be subtle or nonexistent. No sig-
nificant difference was found in the proportion of deaths
from CJD in CWD-endemic versus non–CWD-endemic
counties (adjusted RR 0.81, 95% CI 0.40–1.63). The upper
CI value does not exclude an increased risk for CWD-
endemic county residents, but it is inconsistent with a dra-
matic increase in that risk. Clearly, using residence in a
CWD-endemic county as a surrogate for exposure has
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with no history of hunting or deer and elk consumption are
included in the exposed cohort. Conversely, exposed per-
sons may live outside these counties. Given the potential-
ly long incubation periods associated with prion diseases,
ample opportunity would exist for infected persons to
move from disease-endemic counties before the onset of
illness. Moreover, other unrecognized risk factors (i.e.,
familial CJD or iatrogenic sources of infection) could con-
found epidemiologic investigations.
When Colorado CJD rates were examined over time, no
significant change in CJD deaths was demonstrated (5-
year RR 0.92, 95% CI 0.73–1.16). Although finding that
risk for deaths from neurologic disease decreased over
time under our expanded event definition is reassuring (5-
year RR 0.81, 95% CI 0.77–0.84), this analysis should be
interpreted with caution. The findings could be influenced
by the lack of specificity in the definition and the switch
from ICD-9 to ICD-10 codes in 1999. After excluding
deaths in persons >55 years of age in the expanded defini-
tion, the results became inconclusive.
Although an increase in CJD deaths has not been
observed in Colorado, due to the long incubation periods
of prion diseases, infected persons may not have had suffi-
cient time for disease to develop or may have left the state
before disease onset. Although the prevalence and known
range of CWD has increased over time (2–4), CWD expo-
sure may be decreasing due to ongoing efforts by the pub-
lic health and wildlife management agencies (2–4). Active
education about CWD has been ongoing in northeastern
Colorado since 1995. This information campaign includes
several specific recommendations to minimize exposure
for hunters, meat processors, and taxidermists (4). In addi-
tion, since 1994, testing has been available for game har-
vested in CWD-endemic counties, thereby removing a pro-
portion of harvested, CWD-infected deer and elk from the
human food chain.
Identifying cases of human prion disease remains a
challenge. How human prion disease linked to CWD
would be manifested clinically or pathologically is not
clear. The probability of CJD being accurately diagnosed
is influenced by changes in diagnostic practices; access to
medical care, particularly specialized neurologic consulta-
tions; and the availability of diagnostic testing, including
autopsy and postmortem pathologic examinations.
Improved case ascertainment should result from the estab-
lishment of the National Prion Disease Pathology
Surveillance Center, which offers free diagnostic testing,
complemented by increased Colorado surveillance efforts,
including classifying human prion diseases as a physician-
reportable condition, funding to pay for autopsies, and out-
reach to neurologists, pathologists, and coroners (36).
Increased publicity about BSE, CWD, and human TSEs
may have led to changes in diagnostic practices or case
recognition, particularly in CWD-endemic areas due to a
perceived association of CWD with human disease.
Death certificate data undoubtedly underestimate the
prevalence of CJD. A limitation of this study is that diag-
nosed human TSE cases may not be recorded as CJD on the
death certificate. Between 1998 and 2001, CDPHE surveil-
lance identified 6 persons who died with a medical history
of CJD for whom CJD was not reported on the death cer-
tificate; therefore, those deaths were not captured as events
in our survey, although 3 of these deaths were identified
under our expanded definition. Given that CDPHE surveil-
lance overlapped only the past 4 years of our study, we
could not reclassify these additional TSE deaths as CJD
without introducing an obvious bias in the analysis of year
of death. As a post hoc sensitivity analysis to our primary
CJD endpoint in the CWD county analysis, we reclassified
these 6 missed cases as events and computed the unadjust-
ed RR. Although including these cases changed the CWD
county point estimate from 0.83 (95% CI 0.41–1.68) to 1.16
(95% CI 0.64–2.12), the results remained highly nonsignif-
icant (p = 0.63). The results of this sensitivity analysis
should be interpreted with caution as increasing awareness
of CJD is unlikely to be uniform across a state or country.
In our analysis, this heterogeneous distribution may have
resulted in an increase in misclassification bias over time,
such that reclassifying cases that were not identified on the
death certificate led to identifying an excess of CJD that
was unrelated to exposure in the CWD-endemic counties.
Despite increased scrutiny, evidence of increased CJD
in Colorado has not yet been demonstrated. Smoothed
Colorado CJD annual rates based on death certificate data
are consistently <1 case per million population (median
RESEARCH
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Figure 3. Annual age-standardized Creutzfeldt-Jakob (CJD) death
rates per million population were calculated for chronic wasting
disease (CWD)-endemic ({) and non-CWD-endemic (U) coun-
ties. Population rates were age-standardized to the 2001 age dis-
tribution for Colorado (34). We also display smoothed rates for the
endemic (–) and non-CWD-endemic (·–·) counties.0.88, range 0.65–0.94). In the United Kingdom, which
arguably has the most comprehensive human prion disease
surveillance, the annual crude mortality rates from spo-
radic CJD per million population were 0.86, 1.08, 0.84,
and 0.57 in England, Wales, Scotland, and Northern
Ireland, respectively, over the period from 1990 to 2003
(35). The overall mortality rate from sporadic CJD from
1999 through 2002 in Australia, Canada, United Kingdom,
and 8 additional European countries was estimated to be
1.39 per million population >10 years, although rates were
highly variable across countries (0.48–2.23) (37).
Approximately 84% of Colorado’s population is >10 years
of age (38) such that the comparable median is 1.05 (range
0.77–1.12). Thus Colorado’s CJD rates appear comparable
to or below other reported rates.
Continued case surveillance remains crucial for identi-
fying and characterizing human prion disease (5).
Recognition of CWD transmission to humans will likely
require the identification of a human TSE patient with a
history of exposure to deer or elk, evaluation of the clini-
cal course and pathologic features at autopsy, and charac-
terization of the prion strain in laboratory studies.
Additional epidemiologic studies, such as a case-control
study or cohort study that compares hunter license data
with death certificate data, also should be conducted. Until
the health risks from CWD can be fully ascertained, pre-
ventative steps to reduce exposure to the CWD agent and
other animal prion disease agents (e.g., BSE, scrapie)
should continue (5,30).
CWD has existed in wild deer and elk of northeastern
Colorado for well over 2 decades. However, neither the
number of CJD deaths in CWD-endemic counties nor the
rate of CJD in CWD-endemic counties or in Colorado as a
whole have increased. Although our findings are consistent
with those of other studies that suggest no connection
between CWD and human TSEs (5,12), we cannot exclude
the possibility that an isolated case of human disease asso-
ciated with the CWD agent has occurred or may yet occur.
However, our findings do suggest that death from CJD
remains rare in Colorado.
Acknowledgments
We thank Ken Gershman for his support, input on study
design, and manuscript review; Mary Chase for compiling the
death certificate data; and Mary Lloyd for compiling hunting
license data. We also thank T. Sanders for manuscript review.
This work was funded by an Emerging Infections Program
grant from CDC and the Colorado Division of Wildlife
(M.W.M.).
Dr MaWhinney is an associate professor of preventive med-
icine and biometrics at the University of Colorado at Denver and
Human Prion Disease, Colorado
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 10, October 2006 1533the Health Sciences Center. Her primary research interests are the
application of biostatistical methods to infectious disease data.
References
1. Williams ES, Young S. Chronic wasting disease of captive mule deer:
A spongiform encephalopathy. J Wildl Dis. 1980;16:89–98.
2. Williams ES, Miller MW. Chronic wasting disease in North American
deer and elk. Rev Sci Tech. 2002;21:305–16.
3.  Williams ES, Miller MW. Transmissible spongiform
encephalopathies in non-domestic animals: origin, transmission, and
risk factors. Rev Sci Tech. 2003;22:145–56.
4. Williams ES, Miller MW, Kreeger TJ, Kahn RH, Thorne ET. Chronic
wasting disease of deer and elk: a review with recommendations for
management. J Wildl Manage. 2002;66:551–63.
5.  Belay ED, Maddox RA, Williams ES, Miller MW, Gambetti P,
Schonberger LB. Chronic wasting disease and potential transmission
to humans. Emerg Infect Dis. 2004;10:977–84.
6. Prusiner SB. Neurodegenerative diseases and prions. N Engl J Med.
2001;344:1516–26.
7. Miller MW, Williams ES, McCarty CW, Spraker TR, Kreeger TJ,
Larsen CT, et al. Epizootiology of chronic wasting disease in free-
ranging cervids in Colorado and Wyoming. J Wildl Dis.
2000;36:676–90.
8.  Spraker TR, Miller MW, Williams ES, Getzy DM, Adrian WJ,
Schoonveld GG, et al. Spongiform encephalopathy in free-ranging
mule deer (Odocoileus hemionus), white-tailed deer (Odocoileus vir-
ginianus), and Rocky Mountain elk (Cervus elaphus nelsoni) in
northcentral Colorado. J Wildl Dis. 1997;33:1–6.
9. Alpers MP. Epidemiology and clinical aspects of kuru. In: Prusiner
SB, McKinley MP, editors. Prions: novel infectious pathogens caus-
ing scrapie and Creutzfeldt-Jakob disease. San Diego: Academic
Press; 1987. p. 451–65.
10. Anderson RM, Donnelly CA, Ferguson NM, Woolhouse ME, Watt
CJ, Udy HJ, et al. Transmission dynamics and epidemiology of BSE
in British cattle. [Erratum, Nature 1997;386:302]. Nature.
1996;382:779–88.
11. Raymond GJ, Hope J, Kocisko DA, Priola SA, Raymond LD,
Bossers A, et al. Molecular assessment of the potential transmissibil-
ities of BSE and scrapie to humans. Nature. 1997;388:285–8.
12. Raymond GJ, Bossers A, Raymond LD, O’Rourke KI, McHolland
LE, Bryant PK III, et al. Evidence of a molecular barrier limiting sus-
ceptibility of humans, cattle and sheep to chronic wasting disease.
EMBO J. 2000;19:4425–30.
13. World Health Organization. WHO consultation on public health and
animal transmissible spongiform encephalopathies: epidemiology, risk
and research requirements. Geneva: The Organization; 2000. p. 52. 
14. Belay ED, Gambetti P, Schonberger LB, Parchi P, Lyon DR, Capellari
S, et al. Creutzfeldt-Jakob disease in unusually young patients who
consumed venison. Arch Neurol. 2001;58:1673–8.
15. Food and Drug Administration Transmissible Spongiform
Encephalopathy Advisory Committee. Transcripts of open meeting,
January 18, 2001, Bethesda, Maryland, USA [cited 20006 Aug 8].
Available from http://www.fda.gov/ohrms/dockets/ac/01/tran-
scripts/3681t2_02.pdf 
16. Hamir AN, Cutlip RC, Miller JM, Williams ES, Stack MJ, Miller
MW, et al. Preliminary findings on the experimental transmission of
chronic wasting disease agent of mule deer to cattle. J Vet Diagn
Invest. 2001;13:91–6.
RESEARCH
1534 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 10, October 200617. Gould DH, Voss JL, Miller MW, Bachand AM, Cummings BA, Frank
AA. Survey of cattle in northeast Colorado for evidence of chronic
wasting disease: geographical and high-risk targeted sample. J Vet
Diagn Invest. 2003;15:274–7.
18. Will RG. Epidemiology of Creutzfeldt-Jakob disease. Br Med Bull.
1993;49:960–70.
19. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K,
Alperovitch A, et al. Anew variant of Creutzfeldt-Jakob disease in the
UK. Lancet. 1996;347:921–5.
20. Ghani AC, Ferguson NM, Donnelly CA, Hagenaars TJ, Anderson
RM. Epidemiological determinants of the pattern and magnitude of
the vCJD epidemic in Great Britain. Proc Biol Sci.
1998;265:2443–52.
21. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Predicted
vCJD mortality in Great Britain. Nature. 2000;406:583–4.
22. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Updated pro-
jections of future vCJD deaths in the UK. BMC Infect Dis. 2003;3:4.
23. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Factors
determining the pattern of the variant Creutzfeldt-Jakob disease
(vCJD) epidemic in Great Britain. Proc Biol Sci. 2003;270:689–98.
24. National Creutzfeldt-Jakob Disease Surveillance Unit. CJD statistics
(June 2, 2006) [cited 2006 Aug 8]. Available from
http://www.cjd.ed.ac.uk/figures.htm
25. Clarke P, Ghani AC. Projections of the future course of the primary
vCJD epidemic in the UK: inclusion of subclinical infection and the
possibility of wider genetic susceptibility. Journal of the Royal
Society Interface. 2005;2:19–31.
26. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie
A, et al. Transmission to mice indicate that ‘new variant’ CJD is
caused by the BSE agent. Nature. 1997;389:498–501.
27. Bruce M, Chree A, Williams ES, Fraser H. Perivascular PrP amyloid
in the brains of mice infected with chronic wasting disease. Brain
Pathol. 2000;10:662–3.
28. Race RE, Raines A, Baron TGM, Miller MW, Jenny A, Williams ES.
Comparison of abnormal prion protein glycoform patterns from
transmissible spongiform encephalopathy agent-infected deer, elk,
sheep, and cattle. J Virol. 2002;76:12365–8.
29.  Hamir AN, Kunkle RA, Cutlip RC, Miller JM, O’Rourke KI,
Williams ES, et al. Experimental transmission of chronic wasting dis-
ease agent to cattle by the intracerebral route. J Vet Diagn Invest.
2005;17:276–81.
30. Bosque PJ. Bovine spongiform encephalopathy, chronic wasting dis-
ease, scrapie, and the threat to humans from prion disease epizootics.
Curr Neurol Neurosci Rep. 2002;2:488–95.
31. Majeed A, Lehmann P, Kirby L, Coleman MP. Mortality from demen-
tias and neurodegenerative disorders in people aged 15–64 in
England and Wales in 1979–96. BMJ. 1998;317:320–1.
32.  Collinge J, Rossor M. A new variant of prion disease. Lancet.
1996;347:916–7.
33. National Creutzfeldt-Jakob Disease Surveillance Unit. Incidence of
variant Creutzfeldt-Jakob disease onsets and deaths in the UK,
January 1994–December 2004 [cited 2006 Aug 8]. Available from
http://www.cjd.ed.ac.uk/vcjdq.htm 
34. Colorado Demography Office. Population totals [cited 2006 Aug 8].
Available from http://dola.colorado.gov/demog
35. National Creutzfeldt-Jakob Disease Surveillance Unit. Creutzfeldt-
Jakob disease surveillance in the UK, twelfth annual report, 2003
[cited 2006 Aug 8]. Available from http://www.cjd.ed.ac.uk/
twelfth/rep2003.htm 
37. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, et
al. Mortality from Creutzfeldt-Jakob disease and related disorders in
Europe, Australia, and Canada. Neurology. 2005;64:1586–91.
38. Colorado Demography Office. Population by age and gender [cited
2006 Aug 8]. Available from http://dola.colarado.gov/demog/
CreateTable1.cfm
Address for correspondence: Samantha MaWhinney, University of
Colorado at Denver and Health Sciences Center, 4200 East Ninth Ave,
Campus Box B119, Denver CO 80262, USA; email: Sam.MaWhinney@
UCHSC.edu
Human Prion Disease, Colorado
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 10, October 2006 1535
The print journal is available at no charge to public health professionals
YES, I would like to receive Emerging Infectious Diseases.
Please print your name and business
address in the box and return by fax to
404-639-1954 or mail to
EID Editor
CDC/NCID/MS D61
1600 Clifton Road, NE
Atlanta, GA 30333
Moving? Please give us your new address (in the box) and print the number of your old
mailing label here_________________________________________
	



